1
2
de Vries, S T, Denig, P, Ekhart, C, Burgers, J S, Kleefstra, N, Mol, P G M, van Puijenbroek, E P
Veröffentlicht in: de Vries , S T , Denig , P , Ekhart , C , Burgers , J S , Kleefstra , N , Mol , P G M & van Puijenbroek , E P 2019 , ' Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands : An explorative observational study ' , British Journal of Clinical Pharmacology , vol. 85 , no. 7 , pp. 1507-1515 . https://doi.org/10.1111/bcp.13923;
2019
Veröffentlicht in: de Vries , S T , Denig , P , Ekhart , C , Burgers , J S , Kleefstra , N , Mol , P G M & van Puijenbroek , E P 2019 , ' Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands : An explorative observational study ' , British Journal of Clinical Pharmacology , vol. 85 , no. 7 , pp. 1507-1515 . https://doi.org/10.1111/bcp.13923;
2019
3
Glerum, P.J., Maliepaard, M., de Valk, V., Scholl, J.H.G., van Hunsel, F.P.A.M., van Puijenbroek, E.P., Burger, D.M., Neef, K.
Veröffentlicht in: Glerum , P J , Maliepaard , M , de Valk , V , Scholl , J H G , van Hunsel , F P A M , van Puijenbroek , E P , Burger , D M & Neef , K 2020 , ' Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands ' , Clinical and Translational Science , vol. 13 , no. 3 , pp. 599-607 . https://doi.org/10.1111/cts.12746;
2020
Veröffentlicht in: Glerum , P J , Maliepaard , M , de Valk , V , Scholl , J H G , van Hunsel , F P A M , van Puijenbroek , E P , Burger , D M & Neef , K 2020 , ' Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands ' , Clinical and Translational Science , vol. 13 , no. 3 , pp. 599-607 . https://doi.org/10.1111/cts.12746;
2020
4
Geeven, I.P.A.C., Jessurun, N.T., Wasylewicz, A.T.M., Drent, M., Spuls, P.I., Hoentjen, F., van Puijenbroek, E.P., Vonkeman, H.E., Grootens, K.P., van Doorn, M.B.A., van den Bemt, B.J.F., Bekkers, C.L.
Veröffentlicht in: Geeven , I P A C , Jessurun , N T , Wasylewicz , A T M , Drent , M , Spuls , P I , Hoentjen , F , van Puijenbroek , E P , Vonkeman , H E , Grootens , K P , van Doorn , M B A , van den Bemt , B J F & Bekkers , C L 2022 , ' Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals ' , Expert opinion on drug safety , vol. 21 , no. 5 , pp. 699-706 . https://doi.org/10.1080/14740338.2022.2020756;
2022
Veröffentlicht in: Geeven , I P A C , Jessurun , N T , Wasylewicz , A T M , Drent , M , Spuls , P I , Hoentjen , F , van Puijenbroek , E P , Vonkeman , H E , Grootens , K P , van Doorn , M B A , van den Bemt , B J F & Bekkers , C L 2022 , ' Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals ' , Expert opinion on drug safety , vol. 21 , no. 5 , pp. 699-706 . https://doi.org/10.1080/14740338.2022.2020756;
2022